India Medication Assisted Therapy (MAT) Market to 2032
Overview
The India Medication Assisted Therapy (MAT) Market is expected to reach a 620.28 by 2032 and is projected to grow at a CAGR of 17.46% from 2025 to 2032.
Revenue, 2024 ()
269.04
Forecast, 2032 ()
620.28
CAGR, 2024 - 2032
17.46%
Report Coverage
India
India Medication Assisted Therapy (MAT) Market 2018-2032
India Medication Assisted Therapy (MAT) Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 269.04
- Projected Market Size (2032): 620.28
- CAGR (2025-2032): 17.46%
Key Findings of India Medication Assisted Therapy (MAT) Market
- The India Medication Assisted Therapy (MAT) Market was valued at 269.04 in 2024.
- The India Medication Assisted Therapy (MAT) Market is likely to grow at a CAGR of 17.46% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Adults in Population Type Segment accounted for the largest share of the market with a revenue of 252.76
- The fastest growing segment Buprenorphine and Naloxone in Products Segment grew Fastest with a CAGR of 20.31% during the forecast period from 2024 to 2032.
India Medication Assisted Therapy (MAT) Market Scope
India Medication Assisted Therapy (MAT) Market Segmentation & Scope
Drug Type
- Branded
- Generics
Dosage Form
- Extented Release
- Immediate Release
Route of Administration
- Others
- Parenteral
- Oral
Population Type
- Teenage
- Adults
End User
- Others
- Homecare
- Speciality Centers
- Hospitals
- Rehabilitation Clinics
Type
- Therapy
- Medication
Products
- Acamprosate
- Disulfarm
- Naloxone
- Metadone
- Buprenorphine
- Naltrexone
- Buprenorphine and Naloxone
Distribution Channel
- Others
- Online Pharmacy
- Retail Pharmacy
- Direct Tender
- Hospital Pharmacy
India Medication Assisted Therapy (MAT) Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in |
| Market Value in 2024 | 269.04 |
| Market Value in 2032 | 620.28 |
| CAGR (2025-2032) | 17.46% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Drug Type,Dosage Form,Route of Administration,Population Type,End User,Type,Products,Distribution Channel |
Regional Insights:
-
Leading Market (2024-2032): India, leading in terms of revenue 269.04 in 2024
- Key Country: India, leading in terms of revenue with value of 269.04 in 2024.
Segments and Scope
-
India Medication Assisted Therapy (MAT) Market to 2032, By Drug Type
- Generics is the largest segment in India Medication Assisted Therapy (MAT) Market to 2032 with a revenue of 124.90 in the year 2024.
- Generics is the Fastest growing segment in India Medication Assisted Therapy (MAT) Market to 2032 with a Growth rate of 18.55 % in forecast period 2025-2032.
-
India Medication Assisted Therapy (MAT) Market to 2032, By Dosage Form
- Immediate Release is the largest segment in India Medication Assisted Therapy (MAT) Market to 2032 with a revenue of 89.86 in the year 2024.
- Immediate Release is the Fastest growing segment in India Medication Assisted Therapy (MAT) Market to 2032 with a Growth rate of 18.81 % in forecast period 2025-2032.
-
India Medication Assisted Therapy (MAT) Market to 2032, By Route of Administration
- Oral is the largest segment in India Medication Assisted Therapy (MAT) Market to 2032 with a revenue of 78.77 in the year 2024.
- Oral is the Fastest growing segment in India Medication Assisted Therapy (MAT) Market to 2032 with a Growth rate of 19.11 % in forecast period 2025-2032.
-
India Medication Assisted Therapy (MAT) Market to 2032, By Population Type
- Adults is the largest segment in India Medication Assisted Therapy (MAT) Market to 2032 with a revenue of 252.76 in the year 2024.
- Adults is the Fastest growing segment in India Medication Assisted Therapy (MAT) Market to 2032 with a Growth rate of 17.57 % in forecast period 2025-2032.
-
India Medication Assisted Therapy (MAT) Market to 2032, By End User
- Rehabilitation Clinics is the largest segment in India Medication Assisted Therapy (MAT) Market to 2032 with a revenue of 118.38 in the year 2024.
- Rehabilitation Clinics is the Fastest growing segment in India Medication Assisted Therapy (MAT) Market to 2032 with a Growth rate of 18.67 % in forecast period 2025-2032.
-
India Medication Assisted Therapy (MAT) Market to 2032, By Type
- Medication is the largest segment in India Medication Assisted Therapy (MAT) Market to 2032 with a revenue of 146.73 in the year 2024.
- Medication is the Fastest growing segment in India Medication Assisted Therapy (MAT) Market to 2032 with a Growth rate of 18.23 % in forecast period 2025-2032.
-
India Medication Assisted Therapy (MAT) Market to 2032, By Products
- Buprenorphine and Naloxone is the largest segment in India Medication Assisted Therapy (MAT) Market to 2032 with a revenue of 35.76 in the year 2024.
- Buprenorphine and Naloxone is the Fastest growing segment in India Medication Assisted Therapy (MAT) Market to 2032 with a Growth rate of 20.31 % in forecast period 2025-2032.
-
India Medication Assisted Therapy (MAT) Market to 2032, By Distribution Channel
- Hospital Pharmacy is the largest segment in India Medication Assisted Therapy (MAT) Market to 2032 with a revenue of 80.14 in the year 2024.
- Hospital Pharmacy is the Fastest growing segment in India Medication Assisted Therapy (MAT) Market to 2032 with a Growth rate of 19.10 % in forecast period 2025-2032.
India Medication Assisted Therapy (MAT) Market Company Share Analysis
| Company Name |
|
||
| Viatris Inc. | |||
| Indivior PLC | |||
| Mallinckrodt | |||
| Sun Pharmaceutical Industries Ltd. | |||
| Teva Pharmaceutical Industries Ltd. | |||
India Medication Assisted Therapy (MAT) Market Geographical Sales Distribution, 2018-2032
India Medication Assisted Therapy (MAT) Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The India Medication Assisted Therapy (MAT) Market is segmented based on Segmentation Drug Type,Dosage Form,Route of Administration,Population Type,End User,Type,Products,Distribution Channel.
India Medication Assisted Therapy (MAT) Market was valued at USD 269.04(Revenue in ) in 2020.
India Medication Assisted Therapy (MAT) Market is projected to grow at a CAGR of 17.46% during the forecast period of 2024 to 2032.
The Adults segment is expected to dominate the India Medication Assisted Therapy (MAT) Market, holding a largest market share of 252.76 in 2024
Coming Soon....
India Medication Assisted Therapy (MAT) Market Scope
India Medication Assisted Therapy (MAT) Market Segmentation & Scope
Drug Type
- Branded
- Generics
Dosage Form
- Extented Release
- Immediate Release
Route of Administration
- Others
- Parenteral
- Oral
Population Type
- Teenage
- Adults
End User
- Others
- Homecare
- Speciality Centers
- Hospitals
- Rehabilitation Clinics
Type
- Therapy
- Medication
Products
- Acamprosate
- Disulfarm
- Naloxone
- Metadone
- Buprenorphine
- Naltrexone
- Buprenorphine and Naloxone
Distribution Channel
- Others
- Online Pharmacy
- Retail Pharmacy
- Direct Tender
- Hospital Pharmacy
Frequently Asked Questions
The India Medication Assisted Therapy (MAT) Market is segmented based on Segmentation Drug Type,Dosage Form,Route of Administration,Population Type,End User,Type,Products,Distribution Channel.
India Medication Assisted Therapy (MAT) Market was valued at USD 269.04(Revenue in ) in 2020.
India Medication Assisted Therapy (MAT) Market is projected to grow at a CAGR of 17.46% during the forecast period of 2024 to 2032.
The estimated market value of the India Medication Assisted Therapy (MAT) Market for final year is USD 620.28 ().
India Medication Assisted Therapy (MAT) Market Company Profiling
Frequently Asked Questions
The India Medication Assisted Therapy (MAT) Market is segmented based on Segmentation Drug Type,Dosage Form,Route of Administration,Population Type,End User,Type,Products,Distribution Channel.
India Medication Assisted Therapy (MAT) Market was valued at USD 269.04(Revenue in ) in 2020.
India Medication Assisted Therapy (MAT) Market is projected to grow at a CAGR of 17.46% during the forecast period of 2024 to 2032.
The estimated market value of the India Medication Assisted Therapy (MAT) Market for final year is USD 620.28 ().
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.